SCHEDULE 13G/A
Statement of Beneficial Ownership
CRISPR Therapeutics AG Filed Acc 0000940594-26-000069
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| ORBIS INVESTMENT MANAGEMENT LTD | 4,501,782 | 4.7% |
| Allan Gray Australia Pty Ltd | 17,479 | 0% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…